Lifecore Biomedical Stock Buy Hold or Sell Recommendation
| LFCR Stock | 6.47 0.11 1.73% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Lifecore Biomedical is 'Cautious Hold'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Lifecore Biomedical within the specified time frame.
Check out Lifecore Biomedical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide. Note, we conduct extensive research on individual companies such as Lifecore and provide practical buy, sell, or hold advice based on investors' constraints. Lifecore Biomedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
Lifecore |
Execute Lifecore Biomedical Buy or Sell Advice
The Lifecore recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Lifecore Biomedical. Macroaxis does not own or have any residual interests in Lifecore Biomedical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Lifecore Biomedical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Lifecore Biomedical Trading Alerts and Improvement Suggestions
| Lifecore Biomedical generated a negative expected return over the last 90 days | |
| Lifecore Biomedical has high historical volatility and very poor performance | |
| Lifecore Biomedical has high likelihood to experience some financial distress in the next 2 years | |
| Lifecore Biomedical generates negative cash flow from operations | |
| Lifecore Biomedical has a poor financial position based on the latest SEC disclosures | |
| About 74.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Bronstein, Gewirtz Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. And Encourages Stockholders to Reach Out - Markets Insider |
Lifecore Biomedical Returns Distribution Density
The distribution of Lifecore Biomedical's historical returns is an attempt to chart the uncertainty of Lifecore Biomedical's future price movements. The chart of the probability distribution of Lifecore Biomedical daily returns describes the distribution of returns around its average expected value. We use Lifecore Biomedical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Lifecore Biomedical returns is essential to provide solid investment advice for Lifecore Biomedical.
| Mean Return | -0.06 | Value At Risk | -7.1 | Potential Upside | 6.59 | Standard Deviation | 4.21 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Lifecore Biomedical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Lifecore Stock Institutional Investors
The Lifecore Biomedical's institutional investors refer to entities that pool money to purchase Lifecore Biomedical's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | State Street Corp | 2024-12-31 | 375.3 K | Northern Trust Corp | 2024-12-31 | 221.5 K | Tocqueville Asset Management L.p. | 2024-12-31 | 151.7 K | Marshall Wace Asset Management Ltd | 2024-12-31 | 133.2 K | Quinn Opportunity Partners Llc | 2024-12-31 | 127.9 K | Alpha Wave Global Lp | 2024-12-31 | 116.5 K | Ubs Group Ag | 2024-12-31 | 109 K | Boothbay Fund Management, Llc | 2024-12-31 | 87.1 K | Gamco Investors, Inc. Et Al | 2024-12-31 | 86 K | Wynnefield Capital Inc | 2024-12-31 | 4.7 M | Legion Partners Asset Management, Llc | 2024-12-31 | 4.4 M |
Lifecore Biomedical Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (3.4M) | (6.0M) | (6.1M) | 862K | 775.8K | 814.6K | |
| Change In Cash | (912K) | 742K | 348K | (10.6M) | (9.6M) | (9.1M) | |
| Free Cash Flow | (43.7M) | (8.8M) | (52.5M) | (18.1M) | (16.3M) | (15.5M) | |
| Depreciation | 19.9M | 17.9M | 17.8M | 8.9M | 10.2M | 8.2M | |
| Other Non Cash Items | 33.0M | 23.5M | 66.0M | (20.9M) | (24.1M) | (22.9M) | |
| Capital Expenditures | 26.7M | 23.8M | 28.1M | 17.9M | 20.6M | 16.4M | |
| Net Income | (32.7M) | (97.4M) | (97.2M) | 9.3M | 8.4M | 8.8M | |
| End Period Cash Flow | 553K | 1.3M | 1.6M | 8.5M | 7.6M | 10.9M | |
| Net Borrowings | 41.8M | 7.5M | (55.4M) | 19.4M | 17.5M | 14.9M | |
| Change To Netincome | 29.7M | 18.9M | 61.7M | 32.2M | 37.0M | 31.8M |
Lifecore Biomedical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Lifecore Biomedical or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Lifecore Biomedical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Lifecore stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.03 | |
β | Beta against Dow Jones | 0.42 | |
σ | Overall volatility | 4.27 | |
Ir | Information ratio | 0.01 |
Lifecore Biomedical Volatility Alert
Lifecore Biomedical exhibits very low volatility with skewness of -0.16 and kurtosis of 3.31. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Lifecore Biomedical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Lifecore Biomedical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Lifecore Biomedical Fundamentals Vs Peers
Comparing Lifecore Biomedical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Lifecore Biomedical's direct or indirect competition across all of the common fundamentals between Lifecore Biomedical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Lifecore Biomedical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Lifecore Biomedical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Lifecore Biomedical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Lifecore Biomedical to competition |
| Fundamentals | Lifecore Biomedical | Peer Average |
| Return On Equity | -0.3 | -0.31 |
| Return On Asset | -0.0247 | -0.14 |
| Profit Margin | (0.11) % | (1.27) % |
| Operating Margin | (0.05) % | (5.51) % |
| Current Valuation | 357.37 M | 16.62 B |
| Shares Outstanding | 37.03 M | 571.82 M |
| Shares Owned By Insiders | 4.52 % | 10.09 % |
| Shares Owned By Institutions | 73.59 % | 39.21 % |
| Number Of Shares Shorted | 2.4 M | 4.71 M |
| Price To Book | 15.24 X | 9.51 X |
| Price To Sales | 1.83 X | 11.42 X |
| Revenue | 128.26 M | 9.43 B |
| Gross Profit | 45.64 M | 27.38 B |
| EBITDA | 35.6 M | 3.9 B |
| Net Income | 9.33 M | 570.98 M |
| Total Debt | 130.36 M | 5.32 B |
| Book Value Per Share | 0.42 X | 1.93 K |
| Cash Flow From Operations | (217 K) | 971.22 M |
| Short Ratio | 19.93 X | 4.00 X |
| Earnings Per Share | (0.56) X | 3.12 X |
| Price To Earnings To Growth | 3.51 X | 4.89 X |
| Target Price | 10.0 | |
| Number Of Employees | 524 | 18.84 K |
| Beta | 0.97 | -0.15 |
| Market Capitalization | 239.55 M | 19.03 B |
| Total Asset | 273.7 M | 29.47 B |
| Retained Earnings | (166.52 M) | 9.33 B |
| Working Capital | 42.16 M | 1.48 B |
| Net Asset | 273.7 M |
Note: Disposition of 8975 shares by Paul Josephs of Lifecore Biomedical subject to Rule 16b-3 [view details]
Lifecore Biomedical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Lifecore . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Lifecore Biomedical Buy or Sell Advice
When is the right time to buy or sell Lifecore Biomedical? Buying financial instruments such as Lifecore Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Lifecore Biomedical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Market ETFs Thematic Idea Now
Broad Market ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Market ETFs theme has 72 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Market ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Lifecore Stock Analysis
When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.